TAM-derived CXCL8 promotes MMP-9, VEGF, and E-cadherin expression in bladder cancer cells and enhances bladder cancer cell migration, invasion, and angiogenesis [139]. This evidence concerns the gene CXCL8 and urinary bladder carcinoma.